300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
B2B
Blockchain
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Nigeria
Isle of Man
Pakistan
Puerto Rico
Romania
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Oman
Colombia
Cameroon
Australia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
United Kingdom
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
Peru
Slovenia
San Marino
Ukraine
Ireland
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 20 Life Science Startup Investors in Singapore (June 2026)

The most active venture capital funds and angel investors investing in Singapore Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
EDBI
VC Fund
2 United States, Singapore, India Series C, Series B, Series D Biotechnology, Software, Health Care $12M–$400M
Eisai
VC Fund
2 Japan, United States, China Series A, Series C Biotechnology, Medical, Health Care $3M–$794M
The Venture Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Series B Health Care, Biotechnology, Artificial Intelligence $2.7M–$130M
KT Investment
VC Fund
1 South Korea, United States, Singapore Series A, Series B, Series C Artificial Intelligence, Information Technology, Software $1.7M–$104M
Nestle
VC Fund
1 United States, Germany, United Kingdom Corporate Round, Grant Food and Beverage, Health Care, Food Processing $6k–$150k
Lightstone Ventures
VC Fund
1 United States, Ireland, Singapore Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7M–$105M
M Capital Partners
VC Fund
1 France, United States, Canada Seed, Series A Health Care, Software, Food and Beverage $1.1M–$7.7M
Anzu Partners
VC Fund
1 United States, Canada, Spain Series A, Series B Biotechnology, Software, Manufacturing $5M–$55M
K3 Ventures
VC Fund
1 Singapore, United States, Indonesia Series A, Seed Financial Services, FinTech, Software $1.2M–$42M
SK Securities
VC Fund
1 South Korea, United States, Singapore Series A, Seed, Series B Apps, Health Care, Information Technology $1k–$24M
Partners Investment
VC Fund
1 South Korea, United States, Japan Series B, Series A, Series C Biotechnology, Health Care, Software $1.5M–$98M
Amgen Ventures
VC Fund
1 United States, Canada, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $3.5M–$110M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
1 Japan, United States, India Seed, Series A Health Care, Biotechnology, Medical $3.1M–$85M
Seeds Capital
VC Fund
1 Singapore, United States, Hong Kong Seed, Series A Software, Biotechnology, Health Care $767k–$24M
Altara Ventures
VC Fund
1 Indonesia, Singapore, Philippines Series A, Series B, Series C FinTech, Software, Financial Services $3.9M–$70M
Hana Financial Investment
VC Fund
1 South Korea, Singapore, India Series A, Series B, Seed Information Technology, Biotechnology, Software $860k–$25M
Temasek Holdings
VC Fund
1 United States, China, India Series B, Series C, Series D Biotechnology, Health Care, Software $29M–$500M
KB Financial Group
VC Fund
1 South Korea, India, Vietnam Series A, Series B, Seed Software, Financial Services, SaaS $1M–$104M
Openspace Capital
VC Fund
1 Singapore, Indonesia, Philippines Series A, Series B, Seed E-Commerce, Financial Services, Software $1.9M–$35M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Access all 39 investors in Singapore Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

EDBI
VC Fund · Singapore, Central Region, Singapore · 2 investments in Singapore Life Science startups

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, India

Investor stats

  • Total investments: 187
  • Round size: Series B $19M–$200M; Series C $12M–$275M; Series D $17M–$400M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Thunes — Founded in 2016, Thunes is a global B2B payment infrastructure platform that powers payments for the world’s fastest-growing businesses – from gig economy giants such as Uber and Deliveroo and Southeast Asia’s super-app Grab to global fintech leaders such as PayPal, Remitly, Finastra and Revolut. Through a single, simple connection, consumers andbusinesses can send payments to – and get paid in – every corner of the world. Thunes currently supports 80 currencies, enables payments to 132 countries and helps to accept 300 payment methods. In April 2022, Thunes acquired a controlling stake in a leading anti-money laundering and compliance platform company Tookitaki, which now enables the company’s advanced compliance, anti-fraud and anti-money laundering capabilities, setting an international benchmark for sustainable compliance. The company is headquartered in Singapore, with regional offices in London, Paris, Shanghai, Beijing, Dubai, Hong Kong, Barcelona, Miami and Nairobi. Current investors include Visa, EDBI, Endeavor Catalyst, Marshall Wace, Bessemer Venture Partners, 01Fintech, Future Shape, Insight Partners, Checkout.com, Helios Investment Partners and GGV Capital. For more information, visit www.thunes.com
  • VNLIFE — VNLIFE is a technology company that develops a digital ecosystem for the tourism, logistics, and commerce sector. It enables a full suite of digital products on their payment and service platforms for individual consumers. The company's mission statement is to become the enabler to startups in terms of technical expertise, business guidance,building networks, and capital so as to provide these startups unprecedented opportunity not only to grow their products and services in the domestic market but also to compete in the global arena.
  • Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.
Show all investments...

Eisai
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Singapore Life Science startups

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series C
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 14
  • Round size: Series A $3M–$794M; Series C $46M–$100M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Seed Therapeutics — SEED Therapeutics designs molecular glue degraders using the full E3 ligase universe to eliminate disease proteins across oncology and beyond.
  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
  • Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Show all investments...

The Venture Collective
VC Fund · New York, New York, United States · 1 investments in Singapore Life Science startups

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 53
  • Round size: Seed $2.7M–$20M; Series A $7M–$33M; Series B $13M–$130M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Arogga — Arogga App is the first Bangladeshi app that brought healthcare system to your doorstep. Easy and efficient. With a click of a button, upload your prescription and we will ensure safe delivery of your medicine at earliest possible time.
  • MDisrupt — MDisrupt is health industry expert platform for the digital health industry. We believe the most impactful health products should make it to market faster.
  • Mach — Mach is the global leader in off-road autonomy, trusted by top OEMs for over a decade. We deliver proven full stack solutions, which include ruggedized hardware, scalable software, and advanced AI, across agriculture, land care, construction, mining, defense, and maritime.
Show all investments...

KT Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 77
  • Round size: Series A $1.7M–$26M; Series B $5.9M–$104M; Series C $11M–$97M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Medipal — Medipal provides personal health for a health consultation. It provides subscription-based personal nurse service for patients.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • Twinny — Twinny specializes in the development of self-driving robots.
Show all investments...

Nestle
VC Fund · Vevey, Vaud, Switzerland · 1 investments in Singapore Life Science startups

Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Food Processing
  • Stage:Corporate Round, Grant
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 19
  • Round size: Grant $6k–$150k
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Drools — Discover Drools, the best dog food brand offering premium nutrition for your furry friend. Explore our range of healthy, vet-recommended dog food to keep your pet happy and healthy.
  • Freshly — Our fully-prepared meals are delivered fresh and ready to eat. We can fuel your dietary preference: plant-based, gluten-free, low calorie, low carb, keto, paleo, and more.
  • Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 1 investments in Singapore Life Science startups

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 84
  • Round size: Series A $7M–$105M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investments in Singapore Life Science startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Software, Food and Beverage
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 109
  • Round size: Seed $1.1M–$5.2M; Series A $3.3M–$7.7M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.
  • MilkStraw AI — Saving companies up to 75% on AWS
  • The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
Show all investments...

Anzu Partners
VC Fund · Washington, District of Columbia, United States · 1 investments in Singapore Life Science startups

Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Manufacturing
  • Stage:Series A, Series B
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 77
  • Round size: Series A $6M–$25M; Series B $5M–$55M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
  • AM Batteries — AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology. The company was founded in 2016 and is headquartered in Chelmsford, Massachusetts.
  • South 8 Technologies — South 8's LiGas cells are engineered to deliver unmatched performance and safety in the most demanding environments.
Show all investments...

K3 Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Series A, Seed
  • Geography: Singapore, United States, Indonesia

Investor stats

  • Total investments: 93
  • Round size: Seed $1.2M–$20M; Series A $2M–$42M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Abound — Fintern is a lending startup looking to offer an AI-driven alternative to costly payday loans. It aims to expand access to low-cost personal credit by using the UK’s new Open Banking standard to analyze consumers’ historical bank statement data. Open Banking data allows us to build a granular view of customers’ financial circumstances, properlyunderstand their affordability, and place less reliance on credit reference agency scores.The company was founded in 2020 and is based in London, United Kingdom.
  • Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
  • Validus — Validus Group is the largest SME lending platform in South East Asia, operating in several countries across the region.
Show all investments...

SK Securities
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Show more...

Investment focus

  • Industry: Apps, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 44
  • Round size: Seed $1k–$2.2M; Series A $3k–$24M; Series B $5k–$14M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Kneader — Kneader is a job search platform that offers staffing and recruiting services.
  • Quantum AI — Quantum AI is an AI data company that offers offline and online data collection and analysis services.
  • Gadget Korea — Gadget korea offers data roaming services.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups, 7 in the past 12 months

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 118
  • Round size: Series A $1.5M–$26M; Series B $5M–$98M; Series C $7.4M–$87M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Mustbio — MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
  • BOS Semiconductors — Driving the Future of Automotive, BOS Semiconductors
Show all investments...

Amgen Ventures
VC Fund · San Francisco, California, United States · 1 investments in Singapore Life Science startups

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 110
  • Round size: Series A $3.5M–$42M; Series B $11M–$110M; Series C $19M–$80M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2012

Portfolio highlights

  • Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
  • Mindset Medical — Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 1 investments in Singapore Life Science startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 175
  • Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
  • Metcela — Cells hold endless possibilities. Through science, we will unlock these potentials and harness them to improve the lives of patients worldwide.
  • Startbahn — Startbahn develops Startrail, a sustainable and scalable blockchain infrastructure that assures the reliability, authenticity, and traceability of artworks.
Show all investments...

Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Catalysing smart monies into Singapore-based, early-stage technology startups.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Singapore, United States, Hong Kong

Investor stats

  • Total investments: 130
  • Round size: Seed $767k–$6M; Series A $3.5M–$24M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Biorithm — Biorithm is a company that creates obstetrics remote monitoring platforms and point-of-care devices for pregnant and postnatal patients. The company combines proprietary data analytics software and medical-grade wearables to monitor a wide range of pregnancy vital data such as fetal heart rate, uterine contractions, and maternal heart rate,allowing clinicians to gain new insights into the health of the mother and baby while also providing expecting mothers with better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications.
  • Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative
  • XSQUARE Technologies — XSQUARE sets out to optimise and reshape the warehousing scene by developing a suite of proprietary AGVs and best-in-breed warehouse automation solutions.
Show all investments...

Altara Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.

Show more...

Investment focus

  • Industry: FinTech, Software, Financial Services
  • Stage:Series A, Series B, Series C
  • Geography: Indonesia, Singapore, Philippines

Investor stats

  • Total investments: 23
  • Round size: Series A $4.5M–$13M; Series B $3.9M–$40M; Series C $12M–$70M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Hyper Lounge — Hyperlounge is a startup that has developed a monthly subscription management analysis SaaS by combining management consulting know-how with data collection, analysis and visualization technology. It is a specialized system for small and medium-sized business executives, which is completely different from existing data analysis tools or services.When using this service, user can easily check the core data and analysis necessary for business management every day on mobile without the burden of initial investment or recruitment.
  • Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.
  • KYAN Therapeutics — KYAN Therapeutics is a clinical-stage artificial intelligence company leveraging its proprietary technology platforms to transform the way patients are treated and therapies are developed. KYAN is able to revolutionize the drug development and dosage optimization processes and has multiple pipeline combination therapies in development for oncologyand infectious diseases. KYAN de-risks and dramatically accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN's clinically-validated platforms are uniquely disease-mechanism and indication agnostic.
Show all investments...

Hana Financial Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Show more...

Investment focus

  • Industry: Information Technology, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Singapore, India

Investor stats

  • Total investments: 90
  • Round size: Seed $860k–$7.9M; Series A $1.9M–$25M; Series B $1.6M–$25M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Trustay — Trustay is a real estate asset management company.
  • Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
  • Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.
Show all investments...

Temasek Holdings
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series C, Series D
  • Geography: United States, China, India

Investor stats

  • Total investments: 413
  • Round size: Series B $29M–$300M; Series C $35M–$500M; Series D $45M–$450M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Waymo — Waymo stands for a new way forward in mobility. it is a self-driving technology company with a mission to make it safe and easy for people and things to move around.Waymo improves transportation by building software and sensor technology developed in Google’s labs since 2009. In October 2015, they achieved the world’s first fully self-drivingtrip on public roads, in a car without a steering wheel or pedals. They refine Waymo technology through one billion miles of simulation testing each year, and the cars have self-driven over two million miles on public roads across four U.S. cities.It was founded in 2009 and is located in Mountain View, California.
  • Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
  • LeapFrog Investments — Scaling purpose-driven businesses to achieve leaps of growth, profitability and impact.
Show all investments...

KB Financial Group
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Show more...

Investment focus

  • Industry: Software, Financial Services, SaaS
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, India, Vietnam

Investor stats

  • Total investments: 12
  • Round size: Series A $1M–$45M; Series B $7.4M–$104M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
  • Wavebridge — Wavebridge is a top institutional digital asset company with traditional financial knowhows and crypto finance technology. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
  • BlockOdyssey — BlockOdyssey is a tech start-up that provides 'blockchain-based B2B solutions'.Currently, the main solution is supplying 'blockchain-based anti-counterfeiting solution', and logistics & distribution history management is in progress with blockchain. It has received investment from Asia's largest cosmetic company, andis conducting business with French pharmaceutical companies.
Show all investments...

Openspace Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Series A, Series B, Seed
  • Geography: Singapore, Indonesia, Philippines

Investor stats

  • Total investments: 122
  • Round size: Seed $2.6M–$13M; Series A $1.9M–$20M; Series B $10M–$35M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Igloo — As a top insurtech company, Igloo makes insurance easy across Southeast Asia by working with reputable insurers and distribution partners.
  • Octopus — Integrated Reseller System Fully Automated
  • Kumu Holdings — kumu is a pinoy community platform where you can just hang out, explore the many livestreams the Kumunity has to offer, meet and chat with fellow Filipinos all around the world
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Singapore Life Science startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • DotBio — DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
  • Coastar Therapeutics — Coastar Therapeutics develops an erythrocyte enveloped virus delivery technology platform to perform repeated virus dosing. It evades recognition and attack by the immune system to address the challenges of systemic and repeated administration of drug therapies. Coastar's process technology and “red blood cell membranes only” enable thecompany to overcome the challenges of mass production and standardization, and has cost advantages. The company's first product targets oncolytic viruses and is developing ELCV solutions for other therapies.The company was founded in 2017 and is based in San Diego, CAlifornia.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show all investments...

Life Science Investor funding in Singapore at a glance

Stats across 24 deals from 39 investors.

39
investors
in Singapore Life Science startups
24
deals
in Singapore Life Science startups
$17M
median round
in Singapore Life Science startups
54%
lead investors
lead at least one round
17%
Series A
most common funding stage
97/3
VC / Angel
share of investor count

Access all 39 investors in Singapore Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 39 investors investing in Singapore Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists